Cargando…

Progressive fibrotic interstitial lung disease

Many interstitial lung diseases (ILDs) share mechanisms that result in a progressive fibrosing phenotype. In Brazil, the most common progressive fibrosing interstitial lung diseases (PF-ILDs) are chronic hypersensitivity pneumonitis, idiopathic pulmonary fibrosis, unclassified ILD, and connective ti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pereira, Carlos A C, Cordero, Soraya, Resende, Ana Carolina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Pneumologia e Tisiologia 2023
Materias:	Review and Update Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578905/ https://www.ncbi.nlm.nih.gov/pubmed/37610955 http://dx.doi.org/10.36416/1806-3756/e20230098

Ejemplares similares

Clinical Overview of Progressive Fibrotic Interstitial Lung Disease
por: Case, Amy Hajari
Publicado: (2022)

Factors associated with rapid progression in fibrotic interstitial lung disease
por: Chen, Xianqiu, et al.
Publicado: (2023)

The burden of progressive fibrotic interstitial lung disease across the UK
por: Simpson, Thomas, et al.
Publicado: (2021)

Diagnosis and Pharmacologic Management of Fibrotic Interstitial Lung Disease
por: Berger, Kristin, et al.
Publicado: (2023)

Does methotrexate cause progressive fibrotic interstitial lung disease? A systematic review
por: Dawson, Julie K., et al.
Publicado: (2021)

Clinical Impact of Physical Activity and Cough on Disease Progression in Fibrotic Interstitial Lung Disease
por: Veit, Tobias, et al.
Publicado: (2023)

Endotyping of progressive fibrotic interstitial lung diseases: It is the final destination that matters and not the journey
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players
por: Samarelli, Anna Valeria, et al.
Publicado: (2021)

Dehydroepiandrosterone in fibrotic interstitial lung disease: a translational study
por: Guler, Sabina A., et al.
Publicado: (2022)

Transbronchial Lung Cryobiopsy in the Diagnosis of Fibrotic Interstitial Lung Diseases
por: Casoni, Gian Luca, et al.
Publicado: (2014)

Monitoring clinical progression with mitochondrial disease biomarkers
por: Steele, Hannah E, et al.
Publicado: (2017)

Unmet Needs for Palliation in Fibrotic Interstitial Lung Disease
por: Singhania, Sumeet Vimal Kishore, et al.
Publicado: (2018)

Tracheobronchopathia Osteochondroplastica Associated with Fibrotic Interstitial Lung Disease
por: Heo, Jung Won, et al.
Publicado: (2021)

Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
por: Lamb, Yvette N.
Publicado: (2021)

Fibrotic interstitial lung diseases and air pollution: a systematic literature review
por: Harari, Sergio, et al.
Publicado: (2020)

Multidisciplinary teams in the clinical care of fibrotic interstitial lung disease: current perspectives
por: Cottin, Vincent, et al.
Publicado: (2022)

The Impact of Multidisciplinary Discussion (MDD) in the Diagnosis and Management of Fibrotic Interstitial Lung Diseases
por: Ageely, Ghofran, et al.
Publicado: (2020)

Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease
por: Jehn, Lutz B., et al.
Publicado: (2023)

Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
por: Lamb, Yvette N.
Publicado: (2021)

When should palliative care be introduced for people with progressive fibrotic interstitial lung disease? A meta-ethnography of the experiences of people with end-stage interstitial lung disease and their family carers
por: Palmer, Evelyn, et al.
Publicado: (2022)

Factors influencing self-selected walking speed in fibrotic interstitial lung disease
por: Fischer, Gabriela, et al.
Publicado: (2021)

AZTEC—azithromycin therapy for prevention of chronic lung disease of prematurity: a statistical analysis plan for clinical outcomes
por: Lau, Tin Man Mandy, et al.
Publicado: (2022)

Making Sense of Bronchoalveolar Lavage Lymphocytosis in Fibrotic Interstitial Lung Disease
por: Ryerson, Christopher J.
Publicado: (2020)

Antigenic responses are hallmarks of fibrotic interstitial lung diseases independent of underlying etiologies
por: Yoon, Young me, et al.
Publicado: (2023)

Editorial Comment: Penile prosthesis implant in the special populations: diabetics, neurogenic conditions, fibrotic cases, concurrent urinary continence surgery, and salvage implants
por: Chung, E, et al.
Publicado: (2020)

Autoantibodies are present in the bronchoalveolar lavage but not circulation in patients with fibrotic interstitial lung disease
por: Boustani, Karim, et al.
Publicado: (2022)

Progression of fibrosing interstitial lung disease
por: Wong, Alyson W., et al.
Publicado: (2020)

Protocol update and baseline characteristics for the TRIal to slow the Progression of Diabetes (TRIPOD) randomized controlled trial
por: Bairavi, Joann, et al.
Publicado: (2023)

Inhaled Nitric Oxide for Fibrotic Interstitial Lung Disease: A Step Forward
por: Khor, Yet H., et al.
Publicado: (2022)

Pulmonary Stretch and Lung Mechanotransduction: Implications for Progression in the Fibrotic Lung
por: Marchioni, Alessandro, et al.
Publicado: (2021)

Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review
por: Yamakawa, Hideaki, et al.
Publicado: (2022)

Update of: Choi and Short Fabic, Monitoring Progress in Equality for the Sustainable Development Goals: A Case Study of Meeting Demand for Family Planning
Publicado: (2018)

Reliability of histopathologic diagnosis of fibrotic interstitial lung disease: an international collaborative standardization project
por: Camp, Robert, et al.
Publicado: (2021)

Impaired Right and Left Ventricular Longitudinal Function in Patients with Fibrotic Interstitial Lung Diseases
por: Buonauro, Agostino, et al.
Publicado: (2020)

Effectiveness and cost-effectiveness of a progressive, individualised walking and education program for prevention of low back pain recurrence in adults: statistical analysis plan for the WalkBack randomised controlled trial
por: Pocovi, Natasha C., et al.
Publicado: (2023)

Harnessing PM2.5 Exposure Data to Predict Progression of Fibrotic Interstitial Lung Diseases Based on Telomere Length
por: Shull, Jessica Germaine, et al.
Publicado: (2022)

“Velcro-type” crackles predict specific radiologic features of fibrotic interstitial lung disease
por: Sgalla, Giacomo, et al.
Publicado: (2018)

Symptom prevalence of patients with fibrotic interstitial lung disease: a systematic literature review
por: Carvajalino, Sabrina, et al.
Publicado: (2018)

MEDIASTinal staging of non-small cell lung cancer by endobronchial and endoscopic ultrasonography with or without additional surgical mediastinoscopy (MEDIASTrial): a statistical analysis plan
por: Bousema, Jelle E., et al.
Publicado: (2021)

Diaphragmatic ultrasound findings correlate with dyspnea, exercise tolerance, health-related quality of life and lung function in patients with fibrotic interstitial lung disease
por: Santana, Pauliane Vieira, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bjdiipf3klacooiv5p0m13bmkc